Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass
FISCHER, S, HANEFELD, M, HAFFNER, S. M, FUSCH, C, SCHWANEBECK, U, KÖHLER, C, FÜCKER, K, JULIUS, U
Published in Acta diabetologica (01.09.2002)
Published in Acta diabetologica (01.09.2002)
Get full text
Journal Article
Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone
HANEFELD, M, FISCHER, S, SCHULZE, J, SPENGLER, M, WARGENAU, M, SCHOLLBERG, K, FÜCKER, K
Published in Diabetes care (01.08.1991)
Published in Diabetes care (01.08.1991)
Get full text
Journal Article
Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I
Wildbrett, J, Hanefeld, M, Fücker, K, Pinzer, T, Bergmann, S, Siegert, G, Breidert, M
Published in Experimental and clinical endocrinology & diabetes (1997)
Published in Experimental and clinical endocrinology & diabetes (1997)
Get more information
Journal Article
Relation of free and specifically bound leptin to insulin secretion in patients with impaired glucose tolerance (IGT)
Leonhardt, W, Horn, R, Brabant, G, Breidert, M, Temelkova-Kurktschiev, T, Fücker, K, Hanefeld, M
Published in Experimental and clinical endocrinology & diabetes (1999)
Published in Experimental and clinical endocrinology & diabetes (1999)
Get more information
Journal Article
Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDM
HAFFNER, S. M, HANEFELD, M, FISCHER, S, FÜCKER, K, LEONHARDT, W
Published in Diabetes care (01.09.1997)
Published in Diabetes care (01.09.1997)
Get full text
Journal Article
Significance of triglycerides for other metabolic parameters in the familial metabolic syndrome
Metzler, W, Fücker, K, Schwanebeck, U, Hanefeld, M, Julius, U, Kindel, B, Fischer, S
Published in Deutsche medizinische Wochenschrift (19.09.2003)
Get more information
Published in Deutsche medizinische Wochenschrift (19.09.2003)
Journal Article
Risikofaktoren für Intima-Media-Verdickung: Ist Adiponektin ein unabhängiger Risikofaktor? Die RIAD Studie
Köhler, C, Henkel, E, Schaper, F, Fücker, K, Hanefeld, M
Published in Diabetologie und Stoffwechsel (19.06.2006)
Published in Diabetologie und Stoffwechsel (19.06.2006)
Get full text
Conference Proceeding
Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes
Köhler, C, Temelkova-Kurktschiev, T, Schaper, F, Fücker, K, Hanefeld, M
Published in Deutsche medizinische Wochenschrift (17.09.1999)
Get more information
Published in Deutsche medizinische Wochenschrift (17.09.1999)
Journal Article
Adiponectin und Leptin: postprandialer Verlauf und die Beziehungen zu den Parametern der Insulin-Glukose-Homöostase in verschiedenen Glukosetoleranzstadien
Henkel, E, Menschikowski, M, Köhler, C, Fücker, K, Hanefeld, M
Published in Aktuelle Ernährungsmedizin (01.10.2003)
Published in Aktuelle Ernährungsmedizin (01.10.2003)
Get full text
Conference Proceeding
Efficacy of a combined bezafibrate retard-colestyramine treatment in patients with hypercholesterolemia
Fischer, S, Hanefeld, M, Lang, P D, Fücker, K, Bergmann, S, Gehrisch, S, Leonhardt, W, Jaross, W
Published in Arzneimittel-Forschung (01.04.1990)
Get more information
Published in Arzneimittel-Forschung (01.04.1990)
Journal Article
Different effects of fibrates on the lipoprotein profile. Comparison of the effectiveness of gemfibrozil and bezafibrate in various types of hyperlipoproteinemia
Julius, U, Hora, C, Gross, P, Fücker, K, Bergmann, S, Hanefeld, M
Published in Fortschritte der Medizin (20.12.1992)
Get more information
Published in Fortschritte der Medizin (20.12.1992)
Journal Article